A Study to Assess the Safety and Efficacy of IPN10200 of in Adult Participants With Upper Limb Spasticity.
Status:
Recruiting
Trial end date:
2024-03-29
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200
with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the
total IPN10200 doses(s) that offer the best efficacy/safety profile when used for the
treatment of Adult upper limb (AUL) spasticity.